Artking Global Limited reduced its holdings in SIMCERE PHARMA (02096) by 14 million shares at a price of HK$6.1 per share.
On November 14, Artking Global Limited reduced its holdings of Sinopharm Group (02096) by 14 million shares, at a price of 6.1 Hong Kong dollars per share, with a total amount of 85.4 million Hong Kong dollars.
According to the latest information from the Hong Kong Stock Exchange, on November 14, Artking Global Limited reduced its holdings of SIMCERE PHARMA (02096) by 14 million shares, with a price of 6.1 Hong Kong dollars per share, for a total amount of 85.4 million Hong Kong dollars. After the reduction, the latest number of holdings is approximately 1.788 billion shares, with a new shareholding percentage of 70.75%.
Related Articles
DEXIN SER GROUP (02215) announced annual financial results, with a net loss attributable to shareholders of 219 million yuan, a year-on-year turnaround from profit to loss.
FERRETTI(09638): KKCG Maritime has received a total of 28,000 valid acceptance offers.
New Stock News | Fujian Wanchen Food Group (300972.SZ) submits listing application to Hong Kong Stock Exchange again
DEXIN SER GROUP (02215) announced annual financial results, with a net loss attributable to shareholders of 219 million yuan, a year-on-year turnaround from profit to loss.
FERRETTI(09638): KKCG Maritime has received a total of 28,000 valid acceptance offers.
New Stock News | Fujian Wanchen Food Group (300972.SZ) submits listing application to Hong Kong Stock Exchange again
RECOMMEND
Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026
Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026
Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026
